Back to discover
Drug

Vitamin A

In clinical development
Emerging researchLate-stage developmentRising momentum
Also known as Aquasol A, Infuvite, Infuvite Pediatric, Lactocal+16 more

Aquasol A, Infuvite, Infuvite Pediatric, Lactocal, Lazer Creme, MVC-Fluoride, Multi-Delyn, Poly-Vi-Sol, Poly-Vi-Sol with Iron, Prenatal Rx 1, RETINOL, Tri-Vi-Sol, Tri-Vi-Sol with Iron, Vitafol-One, Vital E- A + D3, Vital E- Newborn, Vital E- Repro, Vitamin A Alcohol, Viva-Drops, retinol (vit A).

6
Research papers
4
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Pilot Trial of Supplemental Vitamin A and Nicotinamide and Levels of Blood Vitamin A and Nicotinamide

Clinical trial2026-03-20Results expected Q1 2028 · ClinicalTrials.gov

A Randomized Double Blinded Trial of Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.

Clinical trial2025-08-12Results expected Q3 2027 · ClinicalTrials.gov

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Vitamin A
Aliases & brands
Aquasol AInfuviteInfuvite PediatricLactocalLazer CremeMVC-FluorideMulti-DelynPoly-Vi-SolPoly-Vi-Sol with IronPrenatal Rx 1RETINOLTri-Vi-SolTri-Vi-Sol with IronVitafol-OneVital E- A + D3Vital E- NewbornVital E- ReproVitamin A AlcoholViva-Dropsretinol (vit A)
RxNorm CUI
11246
ChEMBL ID
CHEMBL986
ATC codes
D10AD02S01XA02A11CA01R01AX02
UNII
G2SH0XKK91

Clinical trials

41 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
41
registered trials across all phases
LATEST COMPLETION 2022
4
Active studies
4
Recruiting
27
Late-stage (III+)
23
Completed
14
Discontinued
PHASE DISTRIBUTIONn = 41
Early Phase 12Phase 12Phase 1 / 22Phase 28Phase 2 / 31Phase 36Phase 412Phase N / A8

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

6 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
19962024
Most influential
Recent papers
Major research themes7
Trace Elements2Vitamins2Antioxidants1Infant, Very Low Birth Weight1Mastitis1Micronutrients1Nervous System Diseases1
Journals, researchers & institutions
Top journals
  • Allergy1
  • Frontiers in immunology1
  • Journal of the National Cancer Institute1
  • Molecules (Basel, Switzerland)1
  • Nutrients1
  • The New England journal of medicine1
Leading researchers
  • Balmes J1
  • Barnhart S1
  • Bauer CR1
  • Berni Canani R1
  • Brodkin CA1
  • Chai W1
  • Chen Y1
  • Cherniack MG1
Leading institutions
free-text, unnormalised
  • ALiCE-Associate Laboratory in Chemical Engineering1
  • CENCIRA Agrofood Research and Innovation Centre1
  • Centre for Innovative Process Engineering (CENTIV) GmbH1
  • Children's Hospital Colorado1
  • Christine Kühne - Center for Allergy Research and Education (CK-CARE)1
  • Clinic of Internal Medicine1

Related drugs

5 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across 2 of the same disease areas as Vitamin A in the shared literature.

2 shared diseases2 shared papers

Studied across 2 of the same disease areas as Vitamin A in the shared literature.

2 shared diseases1 shared paper

Studied across the same disease area as Vitamin A in the shared literature.

1 shared disease2 shared papers

Studied across the same disease area as Vitamin A in the shared literature.

1 shared disease1 shared paper

Studied across the same disease area as Vitamin A in the shared literature.

1 shared disease1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials